Results 1 to 10 of about 239,349 (307)
Late Mortality after Allogeneic Bone Marrow Transplantation in Childhood for Bone Marrow Failure Syndromes and Severe Aplastic Anemia [PDF]
, 2019 Children with bone marrow failure syndromes and severe aplastic anemia (SAA) are treated with allogeneic blood or marrow transplantation (BMT). However, there is a paucity of studies examining late mortality risk after allogeneic BMT performed in ...Hageman, Lindsey, Bhatia, Smita,, Armenian, Saro H.,, Battles, Kevin,, Francisco, Liton,, Arora, Mukta,, Rosenthal, Joseph, Chen, Yanjun,, Wu, Jessica, Ness, Emily, Kung, Michelle, Bhatia, Smita, Battles, Kevin, Holmqvist, Anna Sällfors,, Armenian, Saro H., Parman, Mariel, Kung, Michelle,, Ness, Emily,, Francisco, Liton, Chen, Yanjun, Wu, Jessica,, Holmqvist, Anna Sällfors, Arora, Mukta, Hageman, Lindsey,, Rosenthal, Joseph,, Lund University., Winther, Jeanette Falck,, Winther, Jeanette Falck, Parman, Mariel, +28 morecore +2 more sourcesBone Marrow Transplantation
Surgical Clinics of North America, 1986 The current status of bone marrow transplantation is reviewed. The diseases that are treatable with marrow transplantation, the basic transplant procedure, and the potential complications of marrow transplantation are discussed in detail. The future application of marrow transplantation to additional disease processes is considered.C B, Thompson, E D, Thomasopenaire +4 more sourcesEssential requirements for setting up a stem cell processing laboratory [PDF]
, 2014 The Graft Processing subcommittee of the Worldwide Network for Blood and Marrow Transplantation wrote this guideline to assist physicians and laboratory technologists with the setting up of a cell processing laboratory (CPL) to support a hematopoietic ...Niederwieser, Dietger Walter, Leemhuis, Thomas B., Szabolcs, Paul M., Chabannon, Christian, Padley, Douglas J., Koh, Mickey Boon Chai, Lanza, Francesco, Teshima, Takanori, Keever-Taylor, Carolyn A., Bazarbachi, Ali Abdul Hamid +9 morecore +1 more sourceQuantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation:a Global Observational Study [PDF]
, 2013 Fifty-five years after publication of the first hematopoietic stem cell transplantation this technique has become an accepted treatment option for defined hematologic and non-hematologic disorders.Madrigal, Alejandro, Horowitz, Mary, Passweg, Jakob, Bouzas, Luis Fernando, Szer, Jeff, Niederwieser, Dietger, Gratwohl, Alois, Aljurf, Mahmoud, Iida, Minako, Kodera, Yoshihisa, Worldwide Network Blood Marrow Tra, Pasquini, Marcelo C., Marrow Transplantation,, Lipton, Jeff, Worldwide Network of Blood,, Gratwohl, Michael, Baldomero, Helen, Frauendorfer, Karl +17 morecore +1 more sourceTransplantation of progenitor cells and regeneration enhancement in acute myocardial infarction - (TOPCARE-AMI)
, 2002 Background - Experimental studies suggest that transplantation of blood-derived or bone marrow–derived progenitor cells beneficially affects postinfarction remodeling.Dimmeler, S, Teupe, C, Martin, H, Döbert, N, Hoelzer, D, Lehmann, R, Aicher, A, Schächinger, V, Urbich, C, Assmus, B, Britten, M, Zeiher, AM, Grünwald, F +12 morecore +1 more sourceIntracarotid administration of human bone marrow mononuclear cells in rat photothrombotic ischemia
, 2010 Background: Increasing evidence suggests that cell therapy improves functional recovery in experimental models of stroke and myocardial infarction.Wolf-Rüdiger Schäbitz, Kuhnert, Katharina, Kai Diederich, Jens Minnerup, Minnerup, Jens, Matthias Schilling, Schilling, Matthias, Seeger, Florian Hartmut, Schäbitz, Wolf-Rüdiger, Stefanie Dimmeler, Dimmeler, Stefanie, Florian H Seeger, Diederich, Kai, Katharina Kuhnert +13 morecore +1 more sourceAllogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation
, 2001 Twenty-three children with de novo acute myelogenous leukemia (AML) (n = 20), secondary AML (n = 1), or non-Hodgkin's lymphoma (NHL) (n = 2) underwent allogeneic bone marrow transplantation (alloBMT) for graft failure (n = 1) or recurrent malignancy (n = Cunningham, J. M., Rochester, R. J., Woodard, J. P., Leung, W., Hale, G. A., Tong, Xin, Bowman, L. C., Benaim, E., Heslop, H. E., Srivastava, D. K., Horwitz, E. M., Shearer, P. D. +11 morecore +1 more sourceHigh-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation
, 2001 This retrospective study from the Italian Association of Pediatric Hematology Oncology-Bone Marrow Transplant Group (AIEOP-TMO) reports the results of consolidation with high-dose melphalan and autologous hematopoietic stem cell transplantation (auto ...C. Messina, E. Lanino, M. Caniggia, MELONI, Giovanna, S. Cesaro, Locatelli F. Italian Pediatric Group For Bone Marrow Transplantation, M. Pillon, A. Proglia, S. Bagnulo, A. Pession +9 morecore +1 more sourceClinical utilization of Chimeric Antigen Receptors T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL) - an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT). [PDF]
, 2018 On August 30, 2017, the U.S. Food and Drug Administration (US-FDA) approved tisagenlecleucel (KYMRIAH, Novartis, Basel, Switzerland), a synthetic bioimmune product of anti-CD19 chimeric antigen receptor-T cells (CAR-T), for the treatment of children and ...Liu, Hien D, Aljurf, Mahmoud Deeb, Litzow, Mark R., Litzow, Mark Robert, Carpenter, Paul A, Kansagra, Ankit J., Carpenter, Paul A., Savani, Bipin N., Frey, Noelle V, Komanduri, Krishna V, Kharfan-Dabaja, M. A., Perales, Miguel A, Kharfan-Dabaja, Mohamed A., Johnston, Laura, Gastineau, Dennis A., Johnston, Laura J., Bazarbachi, Ali, Grupp, Stephan A., Bar, Merav, Bollard, Catherine M., Bonini, Chiara, Mufti, Ghulam J., Kebriaei, Partow, Heslop, Helen E, Shah, Nirali N, Kenderian, Saad, Shah, Nirali N., Ghobadi, Armin, Bachanova, Veronika, Jacoby, Elad, Kansagra, Ankit J, Hashmi, Shahrukh K., Kharfan-Dabaja, Mohamed A, Barrett, John A., Grupp, Stephan A, Gastineau, Dennis A, Pavletic, Steven Z., Kenderian, Saad Sirop Irop, Laetsch, Theodore W., Chabannon, Christian, Mohty, Mohamad, Mufti, Ghulam J, Gill, Saar I., Bollard, Catherine M, Bachanova, V., Hill, Joshua A., Shpall, Elizabeth J, Barrett, John A, Perales, Miguel A., Aljurf, Mahmoud, Shpall, Elizabeth J., Maloney, David G., Andritsos, Leslie, Nagler, Arnon, DiPersio, John F., Perales, Miguel Ángel, Laetsch, Theodore W, DiPersio, John F, Hashmi, Shahrukh K, Laetsch, Theodore Willis, Hudecek, Michael, Porter, David L., Heslop, Helen E., Savani, Bipin N, Frey, Noelle V., Komanduri, Krishna V., Liu, Hien D., Hill, Joshua, Hill, Joshua A, Pavletic, Steven Z, Bazarbachi, Ali Abdul Hamid, Gill, Saar I, Porter, David L, Pavletic, Zivko Steven, Sadelain, Michel W.J., Hashmi, Shahrukh Khurshid, Maloney, David, Andritsos, Leslie A., Litzow, Mark R, Sadelain, Michel +79 morecore +1 more sourceClonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia [PDF]
, 2006 s Karyotypic evolution is a well-known phenomenon in patients with malignant hernatological disorders during disease progression. We describe a 50-year-old male patient who had originally presented with pancytopenia in October 1992.Wunderlich, Bettina, Kolb, Hans Jochem, Schmetzer, Helga Maria, Schmid, C., Schmetzer, H.M., Kolb, Hans Jochen, Poleck-Dehlin, Brigitte, Poleck-Dehlin, B., Mittermueller, Johann, Schmid, Christoph, Wunderlich, B., Ledderose, G., Mittermüller, Johann, Schmetzer, Helga, Ledderose, Georg, Duell, T., Mittermüller, J., Kolb, H.-J., Duell, Thomas +18 morecore +1 more source